We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 60,335 | 08:00:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 04/10/2020 20:43 | Developer Synairgen breathes in sweet smell of Covid trial - Sunday Times Shares in the company have shot up since the challenger revealed its treatment for coronavirus could help sufferers recover faster For many, 2020 has been a year of heartbreak. For the army of small investors in experimental drug-maker Synairgen, it has been nothing short of a miracle. Anyone who invested £100 in its shares in January would be £2,700 better off today. The company owes its rocketing valuation to the coronavirus: it has a potential treatment. In July, Synairgen reported positive results from a trial of its drug. The shares jumped by 420% in one day. “It is a thrill to be in this position,” said chief executive Richard Marsden, on a tour of Synairgen’s main trial site at Southampton General Hospital. His excitement was tempered: “It’s in the context of awful destruction happening, people dying, people losing their jobs.”.... | master rsi |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
